Results 171 to 180 of about 395,319 (225)
A 19‐year‐old woman with intermittent headache and dizziness and a large temporal lobe mass
Brain Pathology, Volume 36, Issue 5, September 2026.
Sha‐Sha Hu, Wei Yan, Bo Wang
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Management of Malignant Pleural Effusion
Lung, 2013Malignancy is one of the most common causes of pleural effusion. Malignant pleural effusion is defined by the presence of malignant cells in the pleural fluid. Development of malignant pleural effusion usually defines advanced malignancy. Pathophysiology of malignant pleural effusion is not fully understood and may involve complex interactions between ...
exaly +3 more sources
Clinics in Chest Medicine, 2021
Malignant pleural effusions have a significant burden on patients and the health care system. Diagnosis is typically via thoracentesis, although other times more invasive procedures are required. Management centers around relief of dyspnea and patient quality of life and can be done via serial thoracentesis, indwelling pleural catheter, or pleurodesis.
Christopher M, Kapp, Hans J, Lee
openaire +2 more sources
Malignant pleural effusions have a significant burden on patients and the health care system. Diagnosis is typically via thoracentesis, although other times more invasive procedures are required. Management centers around relief of dyspnea and patient quality of life and can be done via serial thoracentesis, indwelling pleural catheter, or pleurodesis.
Christopher M, Kapp, Hans J, Lee
openaire +2 more sources
Cancer Treatment Reviews, 1978
Recurrent malignant pleural effusion is a relatively common problem that often occurs many months before the terminal stages of a patient's malignant disease. Despite careful evaluation, it is often impossible to identify the exact physiologic cause of an effusion and difficult to identify a pragmatic course of therapy.
M A, Friedman, E, Slater
openaire +2 more sources
Recurrent malignant pleural effusion is a relatively common problem that often occurs many months before the terminal stages of a patient's malignant disease. Despite careful evaluation, it is often impossible to identify the exact physiologic cause of an effusion and difficult to identify a pragmatic course of therapy.
M A, Friedman, E, Slater
openaire +2 more sources
2004
The presence of pleural effusions is a common clinical problem in patients with neoplastic disease. At the time of diagnosis, approximately 15% of lung cancer patients have a pleural effusion (Naito et al. 1997).Twenty to 50% of patients with advanced or disseminated lung cancer develop a pleural effusion during the course of the ir disease (Emerson et
Van Schil, P., Germonpré, P.
openaire +2 more sources
The presence of pleural effusions is a common clinical problem in patients with neoplastic disease. At the time of diagnosis, approximately 15% of lung cancer patients have a pleural effusion (Naito et al. 1997).Twenty to 50% of patients with advanced or disseminated lung cancer develop a pleural effusion during the course of the ir disease (Emerson et
Van Schil, P., Germonpré, P.
openaire +2 more sources
Clinics in Chest Medicine, 2018 Malignant pleural effusion (MPE) refers to the presence of neoplastic cells in the pleural fluid. Approximately 40 000 people per year in the UK are affected by MPE and it is associated with significant morbidity and an overall poor prognosis. Management
Najib M Rahman, Rachelle Asciak
exaly +1 more source
Management of Malignant Pleural Effusions
Drugs, 1998Malignant pleural effusions (MPEs) represent a common complication of advanced malignancies. However, adequate palliation of this highly symptomatic accompaniment to cancer can be achieved in most patients by adopting the appropriate therapy. Several options are available for the treatment of MPE.
Grossi F +4 more
openaire +2 more sources
The treatment of malignant pleural effusions
Cancer, 1974This report reviews a 5-year experience in the treatment of malignant pleural effusion with particular emphasis on the use of closed-tube thoracostomy drainage with nitrogen mustard instillation. Of the 133 patients treated at the Barnes Hospital for malignant pleural effusion between January 1 1964 and December 31 1968 bilateral effusions were ...
C B, Anderson +2 more
openaire +2 more sources
Current Treatment Options in Oncology, 2001
Malignant pleural effusions contribute to considerable morbidity in cancer patients and generally portend an overall poor prognosis. Treatment of malignant pleural effusions is palliative; therefore, quality of life issues, as well as the risks and benefits of the therapeutic options, become more critical.
openaire +2 more sources
Malignant pleural effusions contribute to considerable morbidity in cancer patients and generally portend an overall poor prognosis. Treatment of malignant pleural effusions is palliative; therefore, quality of life issues, as well as the risks and benefits of the therapeutic options, become more critical.
openaire +2 more sources
Fatigue and malignant pleural effusions
BMJ Supportive & Palliative Care, 2021Dear Editors We completely agree with Twose et al 1 that until now the primary focus in both clinical practice and trials has been on interventions in malignant pleural effusions (MPEs), tailored to mitigating breathlessness and preventing admissions, with little consideration of other factors potentially of greater priority to the patient.
Avinash Aujayeb, Donna Wakefield
openaire +2 more sources